Releaf
Oliver Soar is a seasoned technology professional with extensive experience in leadership roles across various companies. As Co-founder and CTO of Releaf since May 2022, Oliver Soar drives innovation and strategic direction. In addition, serving as Technical Director at UK Meds since June 2017, Oliver Soar has contributed to the development of technology solutions in the healthcare sector. Prior experience includes the role of Systems Developer at Yu Energy from December 2014 to May 2017, where Oliver Soar focused on enhancing system functionalities and improving operational efficiencies.
This person is not in any teams
Releaf
1 followers
Releaf, founded in 2022, is a healthcare company dedicated to transforming patient access to Cannabis Based Products for Medical use (CBPMs) in the UK. Despite the legalisation of medical cannabis in 2019, its uptake has been limited. An estimated 1.8 million people in the UK rely on illicit street cannabis for medical purposes, while over 20 million adults could benefit from CBPMs but are unaware of their options. Currently, only around 30,000 people in the UK have an active CBPM prescription. The primary obstacles to broader adoption are the complexity of the prescribing process and a lack of awareness among medical professionals and potential patients. Releaf has made significant investments in developing a HealthTech platform to streamline access to CBPMs for patients with various health conditions. The platform was launched in February 2024, eliminating previous barriers and bringing about fundamental changes in the UK's CBPM sector. Our Leadership Team has a proven track record in navigating complex, regulated markets. Through substantial investments in time, money, and expertise, we have developed Releaf's HealthTech operating platform. This platform simplifies the intricate and makes the opaque transparent, ensuring a seamless, single online session for patients to access CBPMs for their relevant conditions. Press enquiries: Press@releaf.co.uk